Insights from 2023 ASCO® Annual Meeting

 

Sarcoma
12:04

Insights from 2023 ASCO® Annual Meeting

INSIGHT Study - Ripretinib vs. Sunitinib in Patients With Advanced GIST Previously Treated With Imatinib Harboring KIT exon 11 + 17 and/or 18 Mutations

FEATURING Suzanne George
  • 122 views
  • July 17, 2023
07:29

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic Soft Tissue Sarcoma - Cabozantinib +/- PD-1 and CTLA-4 Inhibition"

FEATURING Brian Van Tine
  • 289 views
  • June 15, 2023
  • 1
21:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Radiation Therapy in Metastatic Sarcoma - Modalities, Innovation, and Considerations Across the Ages"

FEATURING Nadia Laack
  • 225 views
  • June 12, 2023
  • 2
12:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Single-Arm, Open-Label Phase 2 Trial of Doxorubicin + Zalifrelimab With Balstilimab in Pts With Advanced/Metastatic Soft Tissue Sarcomas"

FEATURING Breelyn Wilky
  • 120 views
  • June 8, 2023
  • 2
09:02

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609 - The Desmoid Tumors"

FEATURING Young Chae
  • 416 views
  • June 8, 2023
  • 1